Royce & Associates LP reduced its position in shares of Nova Ltd. (NASDAQ:NVMI – Free Report) by 8.3% during the fourth quarter, HoldingsChannel reports. The firm owned 83,480 shares of the semiconductor company’s stock after selling 7,568 shares during the quarter. Royce & Associates LP’s holdings in Nova were worth $27,414,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in NVMI. Measured Wealth Private Client Group LLC acquired a new position in shares of Nova during the third quarter worth $40,000. CIBC Private Wealth Group LLC lifted its position in shares of Nova by 75.7% during the third quarter. CIBC Private Wealth Group LLC now owns 130 shares of the semiconductor company’s stock worth $42,000 after purchasing an additional 56 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its position in shares of Nova by 2,042.9% during the third quarter. Caitong International Asset Management Co. Ltd now owns 150 shares of the semiconductor company’s stock worth $48,000 after purchasing an additional 143 shares in the last quarter. Advisors Asset Management Inc. lifted its position in shares of Nova by 51.6% during the first quarter. Advisors Asset Management Inc. now owns 376 shares of the semiconductor company’s stock worth $69,000 after purchasing an additional 128 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Nova by 62.5% during the second quarter. EverSource Wealth Advisors LLC now owns 260 shares of the semiconductor company’s stock worth $72,000 after purchasing an additional 100 shares in the last quarter. 82.99% of the stock is owned by institutional investors and hedge funds.
Nova Stock Performance
Shares of NASDAQ:NVMI opened at $503.49 on Tuesday. The company has a fifty day simple moving average of $489.07 and a 200 day simple moving average of $419.55. The firm has a market cap of $16.00 billion, a PE ratio of 62.78, a price-to-earnings-growth ratio of 3.69 and a beta of 1.78. Nova Ltd. has a 12-month low of $179.00 and a 12-month high of $565.00.
Analysts Set New Price Targets
A number of research firms have recently commented on NVMI. Wall Street Zen raised shares of Nova from a “sell” rating to a “hold” rating in a research report on Saturday, May 16th. Morgan Stanley set a $494.00 target price on shares of Nova in a research report on Thursday, May 14th. Evercore reissued an “outperform” rating and set a $600.00 target price on shares of Nova in a research report on Friday, May 15th. Needham & Company LLC boosted their target price on shares of Nova from $500.00 to $640.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Finally, Jefferies Financial Group boosted their target price on shares of Nova from $520.00 to $640.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Nine investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Nova presently has an average rating of “Moderate Buy” and an average target price of $518.22.
Read Our Latest Research Report on NVMI
Insiders Place Their Bets
In related news, Director Yaniv Garty sold 426 shares of Nova stock in a transaction on Monday, May 18th. The shares were sold at an average price of $514.49, for a total value of $219,172.74. Following the completion of the sale, the director owned 2,038 shares in the company, valued at approximately $1,048,530.62. The trade was a 17.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Sarit Sagiv sold 426 shares of Nova stock in a transaction on Monday, May 18th. The stock was sold at an average price of $514.49, for a total transaction of $219,172.74. Following the completion of the sale, the director owned 2,437 shares of the company’s stock, valued at approximately $1,253,812.13. This trade represents a 14.88% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 907 shares of company stock valued at $461,720. Insiders own 1.00% of the company’s stock.
Nova Company Profile
Nova Measuring Instruments Ltd (NASDAQ: NVMI) develops and supplies advanced metrology and process control systems for the semiconductor manufacturing industry. The company’s core product line includes spectroscopic ellipsometry and scatterometry tools designed to measure film thickness, critical dimensions, overlay alignment and other key parameters that drive yield and performance in integrated circuit fabrication.
Founded in 1993 and headquartered in Rehovot, Israel, Nova Measuring Instruments has established itself as a critical partner to leading semiconductor foundries and device manufacturers.
Featured Stories
- Five stocks we like better than Nova
- SpaceX Gets the Attention, But These 4 Stocks Could Get the Returns
- Microsoft Stock Discount May Be Ending as AI Catalysts Build
- Apparel Earnings Winners and Losers: Ralph Lauren Takes Off
- Why Walmart, Target and TJX Got Such Different Reactions After Earnings
Want to see what other hedge funds are holding NVMI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nova Ltd. (NASDAQ:NVMI – Free Report).
Receive News & Ratings for Nova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nova and related companies with MarketBeat.com's FREE daily email newsletter.
